Using Inverted Periosteal Pedicle Flap in Treatment of Gingival Recession
NCT ID: NCT03701191
Last Updated: 2020-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
18 participants
INTERVENTIONAL
2020-01-25
2020-08-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periosteal Pedicle Flap Versus Subepithelial Connective Tissue Graft in Management of Gingival Recession
NCT06529640
Treatment of Miller Class I and II Gingival Recession Using Non- Pedicled Buccal Fat Pad Graft as Compared to Subepithelial Connective Tissue Graft
NCT03543163
Treatment of Gingival Recession Using Gingival Composite Restoration Versus Coronally Advanced Flap
NCT04584931
Use of Platelet Rich Fibrin in Addition to CAF and SCTG for Treatment of Gingival Recession
NCT03199118
Bi-layer Collagen Membrane Versus Subepithelial Connective Tissue Graft in the Treatment of Localized Gingival Recession
NCT07162207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Included participants will be:
1. Gender: Male and Female
2. Age: \>20 years
3. Have RT1 and RT2 gingival recession
Exclusion criteria:
1. Medically compromised
2. History of certain medications
3. Pregnant females
4. Periapical involvement in selected teeth
5. History of periodontal surgery involving experimental teeth
6. If the problem was due to orthodontic treatment
11\. Interventions: Participants will be divided into two groups, group A (test group) and group B ( control group).
Pre-surgical phase (including supragingival scaling and root planning) will be carried out to both groups, followed by oral hygiene instructions.
Then, Participants will be explained about each procedure. 7
For group A (test group):
Inverted periosteal pedicle flap will be carried out as follows according to Shetty 2014:
Patients will be explained about the procedure. Non-surgical phase will include supragingival scaling and root planning, followed by oral hygiene instructions.
The surgical procedure will be carried out three weeks after non-surgical phase as follows:
1. Horizontal incisions will be made perpendicular to the adjacent papillae at the level of the cement-enamel junction (CEJ) preserving the gingival margin of the affected teeth.
2. Sulcular incisions on the buccal/facial aspect of the involved teeth.
3. Vertical incisions extending beyond the mucogingival junction will be made at the line angles of the distal most and the mesial most teeth.
4. A partial thickness flap will then be elevated till an adequate amount of periosteum is exposed.
5. A horizontal incision will then be given at the apical extent of the periosteum where it is still attached to the bone.
6. The periosteum will then be separated from the underlying bone and reflected coronally to an extent where it is still attached to the bone.
7. The reflected periosteum will then be inverted such that the cambium layer covers the denuded root.
8. Once the periosteum is in place, it is sutured and secured.
9. The reflected partial thickness flap will be coronally advanced such that it covers the periosteum and will be sutured using a sling suture.
10. The vertical incision will be sutured using an interrupted suture. 8
For group B (control group):
Coronally advanced flap with subepithelial connective tissue graft will be carried out; an envelope flap design will be used according to Zucchelli \& De Sanctis 2000 as follows:
1. An intrasulcular incision will be performed involving at least one tooth mesial and at least one tooth distal to the teeth with gingival recessions.
2. Oblique incisions will be traced at the interdental soft tissue level to achieve a coronal rotation of the surgical papilla.
3. The flap will be then raised up to the mucogingival junction (MGJ) with a periosteal elevator and mobilized with a sharp horizontal periosteal incision beyond the MGJ.
4. Exposed root surfaces will be carefully treated with gentle root planing.
5. The anatomic interdental papillae will be carefully de-epithelialized.
6. The split-full-split thickness flap will be then passively positioned above the CEJ of the involved teeth and interrupted or sling sutures were positioned to achieve optimal buccal flap adaptation.
7. The connective tissue graft will be harvested from the palate using the trap door technique (Langer \& Langer 1985), adapted to cover each exposed root about 1 mm beyond the CEJ, and stabilized with resorbable sutures.
8. The flap will be then coronally sutured using sling or interrupted sutures.
Post-surgical protocol (Pini-Prato et al.,2010 and Cairo et al., 2016) :
Participants for both groups will be instructed to:
1. Intermittently apply an ice bag for the first 4 hours.
2. Take ibuprofen 600 mg at the end of the surgical procedure and will be instructed to take another tablet 6 h later and additional doses if needed.
3. Avoid any mechanical trauma and tooth-brushing for 3 weeks in the surgical area.
4. Smokers will be reminded to quit smoking during the trial time (6 months).
5. Chlorexidine rinses will be prescribed twice daily for 1 min. seven days after the surgery.
6. Sutures will be removed and prophylaxis will be performed. 9
7. About 3 weeks after surgery, patients will be instructed to resume mechanical tooth-cleaning.
Follow up strategy:
Patients will be recalled after 3and 6 months after surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Gender: Male and Female
2. Age: \>20 years
3. Have RT1 and RT2 gingival recession
Exclusion criteria:
1. Medically compromised
2. History of certain medications
3. Pregnant females
4. Periapical involvement in selected teeth
5. History of periodontal surgery involving experimental teeth
6. If the problem was due to orthodontic treatment
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Grpup A (Test group)
Inverted periosteal pedicle flap will be carried out
Inverted periosteal pedicle flap
The periosteum will be used as an autogenous graft after raising a partial thickness flap in group A
Group B (Control group)
Coronally advanced flap with subepithelial connective tissue graft
Inverted periosteal pedicle flap
The periosteum will be used as an autogenous graft after raising a partial thickness flap in group A
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inverted periosteal pedicle flap
The periosteum will be used as an autogenous graft after raising a partial thickness flap in group A
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age: \>20 years
3. Have RT1 and RT2 gingival recession
Exclusion Criteria
2. History of certain medications
3. Pregnant females
4. Periapical involvement in selected teeth
5. History of periodontal surgery involving experimental teeth
6. If the problem was due to orthodontic treatment
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Marwa El Sayed Abbas Ahmed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa El Sayed Abbas Ahmed
Assistant Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university, Faclty of dentistry
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
perio 2:5:1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.